In re Payment Card Interchange Fee and Merchant Discount Antitrust Litigation, MDL No. 1720 (E.D.N.Y.): Serving as court-appointed co-lead counsel, Robins Kaplan reached a $5.6 billion antitrust class action settlement on behalf of a class of more than 10 million U.S. merchants who accepted Visa and Mastercard credit and debit cards for the purchase of goods and services. Plaintiffs alleged that Visa and Mastercard, as well as major card-issuing banks such as JPMorgan Chase, Bank of America, Citibank, Wells Fargo, and Capital One, violated antitrust laws and charged merchants who accept credit and debit cards supra-competitive fees on card transactions. The settlement, which was granted final approval in December of 2019 and affirmed on appeal in March of 2023, represents the largest settlement of a private antitrust action in the 130-year history of the Sherman Act.

BCBSM, Inc. v. GS Labs, LLC, No. 0:22-CV-00513 (D. Minn.): Robins Kaplan represents Blue Cross Blue Shield Minnesota (“BCBSM”) in an ongoing suit alleging that GS Labs engaged in widespread fraudulent COVID testing. In response to our complaint, GS Labs levied 21 counterclaims against BCBSM including allegations of breach of contract, ERISA violations, false advertising, and violation of state and federal antitrust laws. On January 30, 2023, Judge Tostrud of the District of Minnesota issued an order granting our motion as to almost all antitrust and related counterclaims, which represented tens of millions of dollars in potential exposure to BCBSM. Litigation remains ongoing.

Zuchowski v. SFC Global Supply Chain, Inc., No. 1:20-CV-10171 (S.D.N.Y.): Obtained a Rule 12(b)(6) dismissal of a putative nationwide false advertising class action against global food manufacturer SFC Global Supply Chain Inc. (“Schwan’s”). Plaintiffs sought millions in class-wide damages based on alleged false and misleading labeling and marketing of Schwan’s Red Baron pizzas with the use of "preservative-free crust" and "no artificial flavors."

Jackson v. SFC Global Supply Chain, Inc., No. 3:20-CV-01072 (S.D. Ill.): Represented global food manufacturer SFC Global Supply Chain, Inc., in a putative false-advertising class action challenging the labeling of Red Baron pizzas. After most of the damages claims were dismissed under Rule 12(b)(6), achieved a confidential settlement and stipulated dismissal.

In re: LIBOR-Based Financial Instruments Antitrust Litigation, MDL No. 2262 (S.D.N.Y.): Robins Kaplan represents an investment management company that holds financial instruments with provisions to receive interest payments at rates indexed to British Bankers’ Association London Interbank Offered Rate (“BBA LIBOR”) benchmark rates set by defendant banks. Plaintiffs allege that defendants, who are panel bank members that report Intercontinental Exchange (“ICE”) LIBOR rates daily for the benchmark’s calculation, conspired to suppress those rates between August 2007 through at least 2011. The case is ongoing before the trial court.

In re Cattle and Beef Antitrust Litigation, MDL No. 3031 (D. Minn.): Robins Kaplan serves as the court-appointed liaison counsel on behalf of cattle ranchers who sold fed cattle to meatpacking defendants, including Tyson and Cargill, among others. Plaintiffs allege that defendants conspired to suppress the price paid for fed cattle since 2015. The case is ongoing before the trial court.

In re Wholesale Grocery Products Antitrust Litigation, MDL No. 2090 (D. Minn.): Robins Kaplan defended grocery wholesaler Supervalu Inc. in a putative antitrust class action by grocery retailers in 13 states alleging that Supervalu and another wholesaler, C&S Wholesale Grocers, Inc., conspired to allocate territories and customers in the Midwest and New England in violation of the Sherman Act. This significant multidistrict litigation began in 2008 and involved five separate Eighth Circuit appeals and a petition for certiorari to the U.S. Supreme Court. The case was ultimately resolved to the benefit of all parties.

Robins Kaplan represented The Gap Inc. and its subsidiaries in suits seeking relief related to hundreds of store leases affected by COVID-19 store closures and the effects of the pandemic across the United States.

Anthem v. Insys, No. 2:17-CV-02286 (D. Ariz.): Robins Kaplan represented insurer Anthem in litigation against the pharmaceutical manufacturer Insys alleging that Insys marketed Subsys, a powerful painkiller indicated only for cancer patients, to patients who did not have cancer and then lied to Anthem to get the prescriptions paid. On June 10, 2019, the filing was stayed due to Insys’s bankruptcy.

• Amara Legal Center, Co-Founder and Volunteer (2014-2015)
• Lion's Harvest, Board Member (2022-Present)